Isotopic Abundance Yields Bias in the Assessment of Testosterone in a New Reference Method Procedure

To the Editor:
We read with interest the recent publication by Botelho and colleagues describing a candidate reference method procedure for measuring serum testosterone to support the CDC's Hormone Standardization (HoSt) Program (1 ) . The aims of this program are to standardize serum testosterone measurements across laboratories and platforms and to support the generation of age-and sex-specific reference intervals for testosterone. After careful consideration, we have identified a potential error in the assay that could affect the success of the program. Specifically, the final testosterone concentration is determined by multiplying the response ratio of the analyte peak to the internal-standard peak by the concentration of the internal standard. By design, the response ratio is near 1.0, which has previously been demonstrated to reduce the imprecision of measurement (2 ) .
The error in this approach lies in the use of a testosterone internal standard labeled with the 13 C 3 sta- 
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Reference measurement procedures (RMPs) 1 are intended primarily to assign target values to reference materials that function as calibrators or trueness controls for routine measurement procedures (referred to as "routine assays" here). RMPs must be highly accurate and precise to keep the uncertainty of the target values small. This rigor minimizes the increase in measurement uncertainty occurring during the calibration of a routine assay and enables reliable determination of potential measurement bias. To achieve this high level of accuracy, RMPs commonly use special quantification procedures that are different from those used with routine assays. Because of these differences, certain considerations relevant to routine assays may not be applicable to RMPs. Not recognizing these differences can lead to incorrect conclusions about the measurement accuracy of RMPs.
In their letter, Rappold and Grant (1 ) point out a potential source of measurement bias, which can be referred to as bias due to "isotopic enhancement." This bias is different from the more commonly known bias caused by socalled spectral overlap. The RMP described in our article (2 ) is not affected by either of these sources of bias.
Bias due to isotopic enhancement is related to the naturally occurring carbon isotope 13 C, which constitutes 1.1% of carbon and enhances the mass spectrometry response of the 13 C-labeled internal standard (IS). Therefore, a solution of 13 C-labeled IS will produce a higher instrument response for the monoisotopic peak than an equimolar, non-13 C-labeled analyte solution. This phenomenon can lead to a slight bias if the mass spectrometric signals from the IS are directly used for quantification without the use of a calibration curve. The RMP we described does not directly use the mass spectrometry signal from the IS for value assignment, as inferred by Rappold and Grant, but uses a bracketing technique involving calibration with standards prepared gravimetrically.
The bracketing procedure described for our assay (2 ) uses a 2-step process. First, we obtain a 1:1 match of mass concentration between the analyte and the IS and then bracket calibrators around this 1:1 mass ratio to create a calibration curve. Isotopic enhancement in the mass spectrometry signal of the IS is observed in the calibrators to the same extent as in the unknowns and therefore does not affect the quantification of testosterone in the unknown samples. Bracketing and creating calibration curves with brackets is a common technique used by other testosterone RMPs, such as those of NIST (3 ) and Ghent University (4 ).
Spectral overlap due to natural occurring isotopes in the analyte and/or insufficient labeling of the IS is another potential source of bias that is absent from our RMP because of our use of bracketing involving the calibration curves described for our assay. Our RMP is
